| CICLESONIDE | COVIS Pharma | ||
| 0.08MG/INH,0.16MG/INH ; AEROSOL,METERED |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| ALVESCO is an inhaled corticosteroid indicated for: Maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients 12 years of age and older. | |||
|
Yes
| |||
| ALVESCO | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||
| ********* ******* ************ | **** ************* *** ******* ******** | ********* ******* ************ | ********* ******* ************ | **** ************* *** ******* ******** | ****** *** ********** ** ******* | ******-*,*-******,**-*****-**-**-******-** ******, ******* *** ***** ***********, ***********, *** ******* *** *** ********* ** ************ ********** | ********* ******* ******** ********** ************ ** *********** *** ******* ******** | ********* ******* *********** ** *********** *** ******* ********* | *** ** *********** *** *** ********* ** *********** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|